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　Acute myocardial infarction (AMI) is one of the leading causes of death in Japan. Immediate reperfusion therapy, including 
coronary intervention, improves patient prognosis. Despite this, females are said to be more prone to poor prognosis. A regional 
AMI registry in Nagasaki prefecture has been instituted recently that will evaluate whether female gender might predict short-term 
in-hospital death.  Seventeen regional AMI centers enrolled all AMI patients from September 2014 through March 2016. A pro-
pensity score (PS) was derived using logistic regression to model the probability of females as a total function of the potential 
confounding covariates. Two types of PS techniques were used: PS matching and PS stratification. The consistency of in-hospi-
tal death was determined between PS matched patients of both genders. Based on PS, patients were ranked and stratified into 
five groups for the PS stratification. Out of 996 patients, 67 (6.7%) died during hospitalization: 31 (10.4%) out of 298 females and 
36 (5.2%) out of 698 males (p < 0.0025). The proportion of cardiac and non-cardiac related death was almost same between 
genders (25 and 6 in female, 29 and 7 in male, respectively). Among 196 PS matched patients, there was a consistency between 
genders regarding in-hospital deaths (McNemar test, p = 0.6698). The 717 propensity scored patients had no significant differ-
ences between genders among propensity quintiles (Cochran-Mantel-Heanszel test, p = 0.7117). We found that gender alone is 
not an indicator of short-term in-hospital death in acute myocardial infarction patients.
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Introduction
　Cardiovascular disease (CVD) is the primary global cause 
of death in both genders, accounting for 17.3 million deaths 
per year, a number that is expected to increase by 2030 1. 
Therefore, the prevention of atherosclerotic CVD is a 
pressing issue both worldwide and nationwide. The prognosis 
of acute myocardial infarction (AMI) is markedly improved 
by early reperfusion therapy to the occluded culprit coronary 
artery with bare metal or drug-eluting coronary stents, 
though AMI is still a major life-threatening disease.
　CVD or AMI is associated more closely to male gender 
both in medical literature and in popular opinion 2. It may 
cause some shock to hear that those ideas are not actually 
supported by epidemiological data 2. Female gender is thought 
to be at a higher risk of mortality following an AMI 3, 4, but 
negative findings have been reported elsewhere 5, 6. Some 
scholarly articles pointed out the age difference between the 
two genders 7. As noted in the Framingham Heart Study, 
females are approximately ten years older than males at the 
time of a first coronary event 8. It remains uncertain if gender 
makes a difference in mortality or if this observed difference 
is only attributable to different baseline characteristics or 
other factors between females and males suffering from AMI 5.
　The prevalence and incidence of CVD at all ages tends to 
be higher in males than in females 9. But because the female 
to male ratio of the elderly is higher, the absolute number of 
females discharged for CVD is greater than the number of 
males beyond 75 years of age in the U.S.A 9. Therefore, those 
large numbers of elderly female patients might mislead 
clinical impressions. We must be aware of the main 
differences between genders regarding CVD epidemiology 
and clinical presentation 2. To further research into this topic, 
the newly instituted regional AMI registry in Nagasaki 
prefecture aims to find any trends in short-term in-hospital 
death in AMI cases. 
Materials and Methods
Study protocol approval and patient registry
　This study protocol was reviewed by the Clinical Research 
Center of Nagasaki University Hospital and approved by the 
Institutional Review Board of Nagasaki University Hospital. 
Seventeen regional AMI centers were selected to enroll all 
AMI patients from September 2014 through March 2016. 
All were regional cardiovascular centers that accepted all 
AMI patients. 
Diagnosis of acute myocardial infarction
　The standards of AMI diagnosis are based on the Third 
Universal Definition of Myocardial Infarction10. The AMI 
diagnosis is usually based on clinical features, including 
electrocardiographic findings, elevated values of biochemical 
markers (biomarkers) of myocardial necrosis, and imaging, 
or may be confirmed by pathology10. There should be evidence 
of myocardial necrosis, which is marked by a significant cardiac 
biomarker rise and/or fall with at least one of the following: 
symptoms of ischemia; new or presumed significant ST-segment-T 
wave (ST-T) changes or new left bundle branch blocks; 
development of pathological Q waves in the electrocardiogram; 
imaging evidence of new loss of viable myocardium or new 
regional wall motion abnormality; or identification of an 
intracoronary thrombus by angiography or autopsy10.
Clinical data
　Information relevant to the study collected by the AMI 
centers included the following: basic clinical backgrounds 
and characteristics of AMI patients, medical history, 
cardiovascular risk factors, date and time of AMI, any in-
hospital complications, and short-time clinical prognoses. 
All data was entered into a formatted spreadsheet at each 
regional AMI center either by a physician or a physicianʼs 
assistant. All collected data was sent to and received by 
Nagasaki University Hospital.
End points
　The primary statistic required was whether or not the AMI 
patient died in the hospital during index admission. Cardiac 
and non-cardiac deaths (determined by authorities at each 
AMI center) were also reported.
Statistical analysis
　Continuous variables were presented as mean values with 
standard deviations and compared with unpaired t-tests. 
Categorical data were presented in contingency tables, and 
Pearsonʼs chi-square test or Fisherʼs exact test for small 
categorical numbers was used for analysis. Multiple logistic 
regression analysis might be useful to reveal a predictor of 
in-hospital death, but multiple potential confounding factors 
and relatively small numbers of in-hospital deaths limited 
the number of confounding factors for multivariate analysis. 
Instead, propensity score (PS) was expected to reveal the 
influence of gender difference to short-term in-hospital death. 
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A PS was derived using logistic regression to model the 
probability of being a female as a total function of the 
potential confounding seven covariates, i.e., age, body mass 
index, cigarette smoking behavior, presence of dyslipidemia, 
artificial hemodialysis, status of employment, and presence 
of primary care physician. These covariates were selected 
because of the significant differences between in-hospital death 
and hospital discharge among baseline characteristics. The 
area under the fitting curve for PS (i.e., c statistics) was 0.77, 
indicating a relatively strong ability to differentiate between 
two genders. The value of PS ranged from 0.0119 to 0.6769 
and represented the probability that a patient was female. 
　Two types of PS techniques were used to evaluate gender 
differences: PS matching and PS stratification. PS matching 
was performed with a 1:1 nearest-neighbor matching method 
of an add-in macro. If PS was within 0.212 of each other, 
then that was considered a match. Patients were excluded if 
they did not match the PS. Finally, we were able to match 
196 females and 196 males. Between these PS matched 
patients, the consistency of in-hospital death was determined 
by the McNemar test. As the PS matching method would 
decrease the patient numbers because of its nature, PS 
stratification was also performed to 717 propensity scored 
patients. They were ranked and stratified into five groups 
based on their PS. The Cochran-Mantel-Heanszel test was 
the chosen method for this type of analysis. 
　All analyses were performed using JMP Pro 13 software 
(SAS Institute Japan Ltd., Tokyo, Japan). The significance 
level was set at p < 0.05. 
Results
Patient backgrounds and characteristics (Table 1)
　A total of 996 AMI events were logged from September 1, 
2014, through March 31, 2016, by 17 facilities in the Nagasaki 
Table 1. Baseline backgrounds and characteristics of all registered patients with comparison between genders 
Value
Total Female Male p value

















Killip classification (3 or 4)
Creatinine (mg/dL)
HR on admission (bpm)
SBP on admission (mmHg)
DBP on admission (mmHg)






































































































































BMI, body mass index; DM, diabetes mellitus; IGT, impaired glucose tolerance; MI, myocardial infarction; PCI, percutaneous coronary 
intervention; CABG, coronary artery bypass graft; AED, automated external defibrillator; HR, heart rate; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; SpO2, saturation of peripheral oxygen; LMT, left main trunk; TIMI, thrombolysis in myocardial infarction; IABP, 
intra-aortic balloon pumping; PCPS, percutaneous cardio pulmonary support; CHDF, continuous hemodiafiltration; EF, ejection fraction.
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prefecture. Basic clinical characteristics and patient backgrounds 
were listed and then compared to gender (Table 1). Females 
were significantly older (p < 0.0001) and thinner (p < 0.0001) 
than males. Atherosclerotic risk factors, such as glucose 
metabolism abnormality (p = 0.0418), dyslipidemia (p = 
0.0007), and cigarette smoking behavior (p < 0.0001), were 
significantly higher in males than females. Possession of 
hypertension was the same (p = 0.1743) between genders. 
Social status, such as marriage and employment, also had a 
significant difference between genders. Killip classification 
for acute heart failure from AMI was significantly higher 
(p = 0.0281) in females. In females, heart rate at admission 
was significantly higher (p = 0.0379) than that of males, and 
diastolic blood pressure at admission was significantly lower 
(p = 0.0001). Females showed significantly higher instances 
of left main trunk culprit lesions (p = 0.0020) and need for 
respirators (p = 0.0045).
In-hospital death (Table 2 and Table 3)
　Out of 996 patients of both genders, 67 patients (6.7%) 
died during index hospitalization: 31 (10.4%) of 298 females 
Table 3. Comparison of parameters which might relate to in-hospital death in all registered patients 
Value

















Killip classification (3 or 4)
Creatinine (mg/dL)
HR on admission (bpm)
SBP on admission (mmHg)
DBP on admission (mmHg)







































































































BMI, body mass index; DM, diabetes mellitus; IGT, impaired glucose tolerance; MI, myocardial infarction; PCI, 
percutaneous coronary intervention; CABG, coronary artery bypass graft; AED, automated external defibrillator; 
HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; SpO2, saturation of peripheral oxyge
n; LMT, left main trunk; TIMI, thrombolysis in myocardial infarction; IABP, intra-aortic balloon pumping; PCPS, 
percutaneous cardio pulmonary support; CHDF, continuous hemodiafiltration; EF, ejection fraction.
Table 2. In-hospital death and its detail of all registered patients with comparison between genders 
Value
Total Female Male p value
n=996 (%) n=298 (%) n=698 (%) (female vs. male)
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and 36 (5.2%) of 698 males died. Females had a significantly 
higher (p = 0.0025) mortality rate than males before adjustment 
(Table 2). Cardiac and non-cardiac deaths numbered 25 
(8.4%) and 6 (2.0%) in females, respectively; and 29 (4.2%) 
and 7 (1.0%) in males, respectively. The proportion of cardiac 
to non-cardiac death was almost the same between genders 
(p = 0.9926).
　Univariate analyses of patient backgrounds and characteristics 
regarding in-hospital death are listed in Table 3. Many factors 
were significant for in-hospital death, including age (p < 
0.0001) and body mass index (p = 0.0434). Factors such as 
cardiac arrest, automated external defibrillator (AED) usage, 
and higher Killip classifications were more common in in-
hospital death patients than the patients who were discharged. 
Low blood pressure, high heart rate, high creatinine levels, 
and low saturation of peripheral oxygen (SpO2) concentration 
taken at admission were reported significant in in-hospital 
death patients. Other parameters, such as mechanical 
circulation or respiratory support, culprit lesions in the left 
main trunk, low ejection fraction, and unsuccessful 
reperfusion were also dominant in in-hospital death.
Backgrounds and characteristics of matched patients 
(Table 4)
　Table 4 lists and compares the backgrounds and characteristics 
of 196 matched patients of each gender. As mentioned above, 
seven factors were used to derive PS (marked with*). PS 
matching worked relatively well to uniform other factors. As 
a result, spouse, prior percutaneous coronary intervention 
(PCI), and left main trunk (LMT) culprit remained significant, 
and final ejection fraction (EF) became significant.
Table 4. Baseline backgrounds and characteristics of propensity score matched patients
Value

















Killip classification (3 or 4)
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HR on admission (bpm)
SBP on admission (mmHg)
DBP on admission (mmHg)







































































































BMI, body mass index; DM, diabetes mellitus; IGT, impaired glucose tolerance; MI, myocardial infarction; PCI, 
percutaneous coronary intervention; CABG, coronary artery bypass graft; AED, automated external defibrillator; 
HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; SpO2, saturation of peripheral oxyge
n; LMT, left main trunk; TIMI, thrombolysis in myocardial infarction; IABP, intra-aortic balloon pumping; PCPS, 
percutaneous cardio pulmonary support; CHDF, continuous hemodiafiltration; EF, ejection fraction.
* indicates the variable used for PS adjustment.
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In-hospital death of matched patients (Table 5, Table 6, 
and Figure 1)
　Age, body mass index (BMI), and presence of dyslipidemia 
became significantly different between in-hospital deaths 
and survivals in the matched 196 pairs (Table 5). Also, many 
parameters indicating respiratory, circulatory, or renal damage, 
clearly and significantly demonstrated in bad health conditions 
in in-hospital death. Many values were significantly worse 
in in-hospital deaths compared to survivals.
　In this study, PS matched pairs were assumed to have 
similar backgrounds, excluding gender; consequently, if 
gender had no influence, the short-term prognosis should 
have consistency in each matched pair. Out of the 196 
matched pairs, 26 patients (14 females and 12 males) died 
during hospitalization (Table 6), showing that there was 
significant consistency between genders regarding in-
hospital deaths (McNemar test, p = 0.6698). There was no 
statistical difference in in-hospital deaths between genders 
after propensity scores were matched (14 deaths out of 196 
females versus 12 deaths out of 196 males, p = 0.6848).
　The total number of scored patients was 717 (209 females 
and 508 males). The numbers of scored patients in quintile 
(Q1, Q2, Q3, Q4, and Q5) numbered 7, 14, 46, 61, and 81 in 
females, respectively; and 136, 130, 97, 83, 62 in males, 
respectively; and, therefore, 143, 144, 143, 144, and 143 in 
subtotal, respectively. The Cochran-Mantel-Heanszel test was 
the best method for this type of analysis. The 717 propensity 
scored patients had no significant differences between genders 
among propensity quintiles (Figure 1, Cochran-Mantel-
Heanszel test, p = 0.7117). 
Table 5. Comparison of parameters which might relate to in-hospital death in propensity score matched groups 
Value

















Killip classification (3 or 4)
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HR on admission (bpm)
SBP on admission (mmHg)
DBP on admission (mmHg)







































































































BMI, body mass index; DM, diabetes mellitus; IGT, impaired glucose tolerance; MI, myocardial infarction; PCI, 
percutaneous coronary intervention; CABG, coronary artery bypass graft; AED, automated external defibrillator; 
HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; SpO2, saturation of peripheral oxyge
n; LMT, left main trunk; TIMI, thrombolysis in myocardial infarction; IABP, intra-aortic balloon pumping; PCPS, 
percutaneous cardio pulmonary support; CHDF, continuous hemodiafiltration; EF, ejection fraction.
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Discussion
　This study proved the hypothesis that gender is not a risk 
factor of in-hospital death from AMI. Although females have 
a less positive CVD prognosis even after some covariates 
have been adjusted in some literatures 3, 4, we can also find 
the opposite is true in other literatures 5, 6, and our study 
supports the latter. 
　In the present study, AMI patients were enrolled from 17 
regional AMI centers throughout the Nagasaki prefecture. 
All were regional cardiovascular centers that accepted all 
AMI patients. Biases related to omission of certain categories 
of patients were therefore unlikely. Thus, despite a relatively 
small number of enrollment, extrapolation of the results may 
be more reliable than other previous reports.
　Atherosclerotic cardiovascular disease is the dominant 
cause of death in western and modern countries and its death 
toll is expected to increase 1. Currently no difference is seen 
in treatment guidelines for female patients for the vast 
majority of atherosclerotic risk factors 2. In the United States 
since the 1980s, the annual CVD mortality rate has remained 
higher in females than in males, as has the prevalence of 
CVD11. In Brazil, from 1980 to 2012, there was a significant 
reduction in cardiovascular mortality among males, particularly 
for CVD mortality, but no improvement was seen among 
females12. Age of the patient could explain the difference 3, 7, 
We need to look for the reason for the increase of atherosclerotic 
disease and prepare for the fight against it. If female gender 
Table 6. Distribution of in-hospital death and hospital discharge between propensity score matched 
females and males 
Female










Total 14 182 196
McNemar test for consistency demonstrates p = 0.6698; marginal frequencies are not different.
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Propensity quintiles of scored patients2
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F, female; M, male 4
Propensity Quintiles
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Figure 1. Each gender is divided into five sub classifications according to propensity scores. 
Cochran-Mantel-Heanszel analysis shows no significance (p = 0.6795).
F, female; M, male
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itself is a risk factor, we may not yet have useful tools to 
improve prognoses. Fortunately, our results proved that 
gender is not a risk factor of in-hospital death from AMI. 
　The patients who suffered AMI and whose information 
was recorded in this registry had heterogynous backgrounds 
and characteristics. Simple univariate analysis makes gender 
look like a risk factor of in-hospital death. Two techniques, 
PS matching and PS stratification, were used in this study. By 
using the PS matching method, backgrounds of both genders 
became relatively homogenous as shown in Table 4. It is 
interesting to note that when we adjust patientsʼ backgrounds 
with some covariates, significant other differences disappeared 
between genders. PS stratification is another technique to 
ameliorate confounding effects of the variables included in 
the PS. When stratification is used, Rosenbaum and Rubin 
recommend using quintiles13. This is based on results from 
Cochranʼs evaluations of various sub classification strategies14.
　Based on other literature 3, 7, an important value could be 
a patientʼs age. Because an accumulation of atherosclerotic 
CVD risk factors has already started in younger generations, 
and because the female sex hormone protects against 
atherosclerosis progression, CVD such as AMI is dominant 
in males during relatively younger generations, whereas 
females start to deteriorate after menopause. Furthermore, 
recent progression of longevity of both genders, especially 
in females, has changed the proportion of female AMI. As 
people age into their eighties or nineties, females survive to 
become a large number of the patients. The dominance in 
absolute number of females in an older generation resulted 
in the increase of female AMI, even though the incidence of 
AMI in females is still less than in males when we compare 
the data in the same generation 9. We might reach a wrong 
conclusion if we compare two genders without adjusting 
covariant, especially age. Absolute female proportion in 
AMI onset of this study is shown in Figure 2. We realize that 
females are dominant in AMI after age 80.
　On the other hand, a female suffering an AMI often receives 
less intensive medical therapy and is also less likely to undergo 
cardiac catheterization or to receive timely reperfusion 2. Not 
surprisingly, that can translate into unfavorable prognoses 
for females compared to males 2. In this study, we did not 
observe any differences between genders regarding their 
AMI timeline, such as onset to hospital door or hospital door 
to reperfusion. Also, treatment strategies, such as rate of 
emergent cardiac catheterization, cardiac or circulation support 
system usage, or stent usage, are not different between 
genders (data not shown). This may affect our result showing 
that females are not at an increased risk of in-hospital death 
in this study.
　There are several limitations in this study. First, this is an 
observational registration study; therefore, we cannot avoid 
confounding factors. To eliminate as many as possible, we 
need many registrations, but this study was relatively small. 
This time, we used PS to eliminate the defect of observational 
registration. Meta-analysis with large numbers would be one 
remedy. Second, we did not collect medical treatment data, 
such as administration of aspirin, anti-platelet drugs other 
than aspirin, angiotensin-converting enzyme (ACE) inhibitors, 
angiotensin receptor blockers, or ß-adrenergic blockers. 
Although evidence-based medical treatment after AMI is 
36
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Figure 2. The proportion of females in the population increases dramatically as the 
age of AMI onset increases.
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recommended in guidelines, the treatment depends on, and 
varies with, physicians. Some medications given to patients 
after the admission might affect in-hospital death, but we 
cannot test this theory without data. Third, we focused only 
on gender differences. One article concluded that gender-
related differences in short-term mortality of AMI are age-
dependent15. Because the validity of observational registration 
may be limited by confounding factors, we performed a 
propensity analysis focused on genders. PS is an established 
method to eliminate confounding factors, but it must be 
focused on one factor, not two or more. Another limitation of 
PS is that it cannot control for unobserved confounders like 
many other statistical approaches. And after the PS was 
matched, we needed to be careful to determine if the matched 
population was representative of the whole of registry.
　In conclusion, we demonstrated in this study that gender 
is not a risk factor of in-hospital death from AMI by using 
the PS matching and the PS stratification method.
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